University of Dundee

Molecular Microbiology

Short Code: 

Tenovus Scotland funding success for Life Sciences researchers.

Dr Helge Dorfmueller and Dr Harunori Yoshikawa have been awarded Tenvous Scotland grants in the most recent round of funding.

Dr Dorfmueller, a Principal Investigator in the Division of Molecular Microbiology, was awarded a 2 year large research grant worth almost £100k. The funding will allow Dr Dorfmueller to investigate a biosynthetic carbohydrate as a vaccine candidate for Streptococcus pyogenes infections. S. pyogenes is a major human pathogen, causing more than 500,000 deaths annually worldwide.

Positions in Microbiology

The Division of Molecular Microbiology, within the School of Life Sciences at the University of Dundee, UK, is pleased to announce an exciting opportunity for at least three new members of staff to join us and expand our world-class microbiology research and education programmes. We are looking to appoint to any position on the University salary scale from Principal Investigator, Senior Lecturer, Reader or Professor. A strong recruitment package will be made available to candidates at all levels of appointment.

Fleming Prize for Sarah Coulthurst

Dr Sarah Coulthurst has been awarded one of the most prestigious prizes in microbiology for her work studying how bacteria are able to cause disease.  

Dr Coulthurst, Wellcome Trust Senior Research Fellow in the University’s School of Life Sciences, has been awarded the Fleming Prize, one of the top honours bestowed by the Microbiology Society. She will receive a £1000 cash prize and has the honour of delivering the 2018 Fleming Prize Lecture at the Microbiology Society’s 2018 Annual Conference in Birmingham in April.  

4 Year Wellcome Trust PhD Programme: Functional and structural studies of the biosynthesis of a novel Streptococcus pyogenes virulence factor

The Helge Dorfmueller (HD) lab is a young lab in the dynamic and vibrant Division of Molecular Microbiology. HD's research focus lies on understanding the molecular details of how the human-exclusive pathogen Streptococcus pyogenes (GAS) synthesises an essential virulence factor. GAS is a severe burden to human life, causing a range of mild and severe, invasive infections with high morbidity and mortality rates (> 500,000 death / per year). The number of invasive strains increases worldwide.

4 Year Wellcome Trust PhD Programme: Understanding the role and mode of action of a bacterial nanoweapon

Many bacterial pathogens use the Type VI secretion system (T6SS) nanomachine to fire toxic ‘effector’ proteins directly into target cells. It is becoming increasingly apparent that the T6SS plays a key role in the virulence and competitiveness of diverse Gram-negative bacteria, including important human pathogens. Pathogens can use T6SSs to directly target eukaryotic organisms, as classical virulence factors. Alternatively, many pathogens can use T6SSs to target other bacterial cells, killing or inhibiting rivals.